English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  A progressive development of hepatic steatosis with an increase in the lipid hepatocyte content and the formation of megamitochondria have been demonstrated in rats with prehepatic portal hypertension. The aim of this study is to verify the existence of liver and serum lipid metabolism impairments in rats with long-term (2 years) portal hypertension.    Methods  Male Wistar rats: Control (n = 10) and with prehepatic portal hypertension by triple partial portal vein ligation (n = 9) were used. Liver content of Triglycerides (TG), phospholipids (PL) and cholesterol and serum cholesterol, lipoproteins (HDL and LDL), TG, glucose and Lipid Binding Protein (LBP) were assayed with specific colorimetric commercial kits. Serum levels of insulin and somatostatin were assayed by RIA.    Results  The liver content of TG (6.30 ± 1.95  vs . 4.17 ± 0.59 μg/ml; p < 0.01) and cholesterol (1.48 ± 0.15  vs . 1.10 ± 0.13 μg/ml; p < 0.001) increased in rats with portal hypertension. The serum levels of cholesterol (97.00+26.02  vs . 114.78 ± 37.72 mg/dl), TG (153.41 ± 80.39  vs . 324.39 ± 134.9 mg/dl; p < 0.01), HDL (20.45 ± 5.14  vs . 55.15 ± 17.47 mg/dl; p < 0.001) and somatostatin (1.32 ± 0.31  vs . 1.59 +0.37 mg/dl) decreased, whereas LDL (37.83 ± 15.39  vs . 16.77 ± 6.81 mg/dl; p < 0.001) and LBP (308.47 ± 194.53  vs . 60.27 ± 42.96 ng/ml; p < 0.001) increased.    Conclusion  Portal hypertension in the rat presents changes in the lipid and carbohydrate metabolisms similar to those produced in chronic inflammatory conditions and sepsis in humans. These underlying alterations could be involved in the development of hepatic steatosis and, therefore, in those described in the metabolic syndrome in humans.

Chronic prehepatic portal hypertension in the rat: is it a type of Metabolic Inflammatory Syndrome?